INVO Fertility, Inc. IVF
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 7.95% | 27.28% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.95% | 27.28% | |||
| Cost of Revenue | 9.74% | 23.02% | |||
| Gross Profit | 4.80% | 35.56% | |||
| SG&A Expenses | -12.38% | 20.05% | |||
| Depreciation & Amortization | 2.03% | 4.62% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.91% | 20.38% | |||
| Operating Income | 18.94% | -12.65% | |||
| Income Before Tax | 117.06% | -397.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 116.04% | -375.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 116.04% | -375.59% | |||
| EBIT | 18.94% | -12.65% | |||
| EBITDA | 21.00% | -13.52% | |||
| EPS Basic | 112.48% | -703.19% | |||
| Normalized Basic EPS | 81.26% | -156.11% | |||
| EPS Diluted | 110.35% | -705.35% | |||
| Normalized Diluted EPS | 84.78% | -156.11% | |||
| Average Basic Shares Outstanding | 28.55% | 352.71% | |||
| Average Diluted Shares Outstanding | 58.25% | 352.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||